Kazuo Koshiya

569 total citations
25 papers, 509 citations indexed

About

Kazuo Koshiya is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Kazuo Koshiya has authored 25 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Kazuo Koshiya's work include Neuroscience and Neuropharmacology Research (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neuropeptides and Animal Physiology (6 papers). Kazuo Koshiya is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neuropeptides and Animal Physiology (6 papers). Kazuo Koshiya collaborates with scholars based in Japan, Norway and United States. Kazuo Koshiya's co-authors include Shin‐ichi Yatsugi, Sachiko Kawasaki‐Yatsugi, Shuichi Sakamoto, Masao Shimizu‐Sasamata, Shinji Usuda, Takeshi Kato, Tokio Yamaguchi, Ryo Tanaka, Taiji Kato and Takeshi Kato and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

Kazuo Koshiya

25 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuo Koshiya Japan	14	343	245	92	52	49	25	509
Dominique Quarteronet France	8	426 1.2×	306 1.2×	61 0.7×	30 0.6×	25 0.5×	10	563
María Jesús Miranda Montero Germany	12	242 0.7×	196 0.8×	137 1.5×	91 1.8×	23 0.5×	33	827
F. Imbault France	6	529 1.5×	345 1.4×	114 1.2×	37 0.7×	66 1.3×	8	805
Sachiko Kawasaki‐Yatsugi Japan	15	335 1.0×	226 0.9×	132 1.4×	57 1.1×	24 0.5×	25	537
Naohisa Fukuda Japan	12	274 0.8×	119 0.5×	74 0.8×	28 0.5×	26 0.5×	19	510
Nigel Deeks United Kingdom	8	350 1.0×	301 1.2×	63 0.7×	51 1.0×	39 0.8×	11	608
Anne M. Morin United States	13	256 0.7×	226 0.9×	63 0.7×	46 0.9×	31 0.6×	20	516
Philip F. Morgan United States	15	402 1.2×	447 1.8×	58 0.6×	37 0.7×	116 2.4×	25	853
Kaisa Hellevuo United States	14	405 1.2×	319 1.3×	42 0.5×	39 0.8×	18 0.4×	26	657
Maria S. Quinton United States	13	297 0.9×	204 0.8×	65 0.7×	87 1.7×	23 0.5×	21	543

Countries citing papers authored by Kazuo Koshiya

Since Specialization

Citations

This map shows the geographic impact of Kazuo Koshiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Koshiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Koshiya more than expected).

Fields of papers citing papers by Kazuo Koshiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Koshiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Koshiya. The network helps show where Kazuo Koshiya may publish in the future.

Co-authorship network of co-authors of Kazuo Koshiya

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Koshiya. A scholar is included among the top collaborators of Kazuo Koshiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Koshiya. Kazuo Koshiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurihara, Hiroki, Tetsuya Furuya, Atsushi Tanaka, et al.. (2000). Design of the Y₁‐receptor‐selective cyclic peptide based on the C‐terminal sequence of neuropeptide Y. Journal of Peptide Research. 56(6). 409–415. 7 indexed citations

Sonoda, Rie, et al.. (2000). Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus. Psychopharmacology. 148(3). 281–288. 19 indexed citations

Akiho, Hiraku, Akihiko Iwai, Shin‐ichi Tsukamoto, Kazuo Koshiya, & Tokio Yamaguchi. (1998). Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats. Neuropharmacology. 37(2). 159–168. 4 indexed citations

Akiho, Hiraku, et al.. (1998). Neuroprotective Effect of YM-39558, Orotic Acid Ethylester, in Gerbil Forebrain Ischemia. The Japanese Journal of Pharmacology. 76(4). 441–444. 4 indexed citations

Takahashi, Masayasu, Sachiko Kawasaki‐Yatsugi, Takashi Toya, et al.. (1998). Neuroprotective Efficacy of YM872, an α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptor Antagonist, after Permanent Middle Cerebral Artery Occlusion in Rats. Journal of Pharmacology and Experimental Therapeutics. 287(2). 559–566. 14 indexed citations

Takahashi, Masayasu, Sachiko Kawasaki‐Yatsugi, Takashi Toya, et al.. (1998). YM872, a Novel Selective α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Antagonist, Reduces Brain Damage after Permanent Focal Cerebral Ischemia in Cats. Journal of Pharmacology and Experimental Therapeutics. 284(2). 467–473. 24 indexed citations

Kawasaki‐Yatsugi, Sachiko, et al.. (1997). Neuroprotective Effect of YM9OK, an AMPA-Receptor Antagonist,against Delayed Neuronal Death Induced by Transient Global Cerebral Ischemia in Gerbils and Rats.. The Japanese Journal of Pharmacology. 74(3). 253–260. 30 indexed citations

Takeuchi, Hiromi, Shin‐ichi Yatsugi, Kenichi Hatanaka, et al.. (1997). Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity. European Journal of Pharmacology. 329(1). 27–35. 34 indexed citations

Akiho, Hiraku, et al.. (1997). Post-ischaemic treatment with orotic acid prevents neuronal injury in gerbil brain ischaemia. Neuroreport. 8(3). 607–610. 7 indexed citations

10.

Kawasaki‐Yatsugi, Sachiko, Shin‐ichi Yatsugi, Kazuo Koshiya, & Masao Shimizu‐Sasamata. (1997). Neuroprotective Effect of YM90K, an AMPA-Receptor Antagonist, against Delayed Neuronal Death Induced by Transient Global Cerebral Ischemia in Gerbils and Rats. The Japanese Journal of Pharmacology. 74(3). 253–260. 3 indexed citations

11.

Shimizu‐Sasamata, Masao, Sachiko Kawasaki‐Yatsugi, Masamichí Okada, et al.. (1996). YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 84–92. 77 indexed citations

12.

Yatsugi, Shin‐ichi, M Takahashi, Sachiko Kawasaki‐Yatsugi, et al.. (1996). Neuroprotective Effect of YM90K, a Novel AMPA/Kainate Receptor Antagonist, in Focal Cerebral Ischemia in Cats. Journal of Cerebral Blood Flow & Metabolism. 16(5). 959–966. 46 indexed citations

13.

Wanibuchi, Fumikazu, Hiroshi Yamashita, Kazuyuki Hidaka, et al.. (1994). Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies. European Journal of Pharmacology. 265(3). 151–158. 36 indexed citations

14.

Miura, Masaki, Akio Inui, Naohiko Ueno, et al.. (1994). Dynorphin binds to neuropeptide Y and peptide YY receptors in human neuroblastoma cell lines. American Journal of Physiology-Endocrinology and Metabolism. 267(5). E702–E709. 6 indexed citations

15.

Yamashita, Hiroshi, Fumikazu Wanibuchi, Kazuyuki Hidaka, et al.. (1993). Effects of a novel muscarinic agonist YM796 on spatial and working memory impairments in rats.. The Japanese Journal of Pharmacology. 61. 91–91. 1 indexed citations

16.

Koshiya, Kazuo, Tomoyo Morita, & Shinji Usuda. (1992). BEHAVIORAL SUPPRESSIVE AND DISINHIBITORY EFFECTS OF NEMONAPRIDE: POSSIBLE BIOLOGICAL BASIS OF ITS ANTIPSYCHOTIC EFFICACIES.. Clinical Neuropharmacology. 15. 453B–453B. 1 indexed citations

17.

Koshiya, Kazuo & Shinji Usuda. (1989). Suppressive effect of the selective D2 antagonist YM-09151 on the methamphetamine-induced stereotypy in naive and chronically methaiiphetamine-treated rats. The Japanese Journal of Pharmacology. 49. 227–227. 4 indexed citations

18.

Koshiya, Kazuo, Masamichí Okada, Kiyoshi Imai, et al.. (1985). Localization of angiotensin-converting enzyme, prolyl endopeptidase and other peptidases in cultured neuronal or glial cells. Neurochemistry International. 7(1). 125–130. 14 indexed citations

19.

Koshiya, Kazuo, Taiji Kato, Ryo Tanaka, & Takeshi Kato. (1984). Brain peptidases: Their possible neuronal and glial localization. Brain Research. 324(2). 261–270. 47 indexed citations

20.

Koshiya, Kazuo & Takeshi Kato. (1983). Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(3). 223–227. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact